BioHarvest Sciences (NASDAQ:BHST) Shares Up 0.9% – Here’s What Happened

BioHarvest Sciences Inc. (NASDAQ:BHSTGet Free Report)’s share price traded up 0.9% during trading on Monday . The stock traded as high as $4.40 and last traded at $4.31. 19,419 shares traded hands during trading, an increase of 12% from the average session volume of 17,297 shares. The stock had previously closed at $4.27.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on BHST shares. Roth Mkm started coverage on BioHarvest Sciences in a report on Thursday, February 19th. They issued a “buy” rating and a $10.00 target price for the company. Weiss Ratings restated a “sell (d-)” rating on shares of BioHarvest Sciences in a report on Monday, December 29th. Three research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $13.00.

Check Out Our Latest Stock Report on BHST

BioHarvest Sciences Stock Up 0.7%

The firm’s fifty day moving average price is $4.66 and its two-hundred day moving average price is $6.75. The stock has a market cap of $85.54 million, a price-to-earnings ratio of -6.41 and a beta of 1.14. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.35 and a quick ratio of 1.02.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in BHST. Virtu Financial LLC acquired a new stake in BioHarvest Sciences in the fourth quarter valued at approximately $60,000. Geode Capital Management LLC acquired a new position in shares of BioHarvest Sciences during the fourth quarter worth approximately $61,000. HRT Financial LP bought a new position in shares of BioHarvest Sciences in the 4th quarter worth $75,000. Marshall Wace LLP acquired a new stake in BioHarvest Sciences in the 4th quarter valued at $110,000. Finally, Quadrature Capital Ltd acquired a new stake in BioHarvest Sciences in the 4th quarter valued at $140,000.

BioHarvest Sciences Company Profile

(Get Free Report)

BioHarvest Sciences Inc is a biotechnology company that specializes in the development and commercialization of plant-based active ingredients through proprietary cell-culture technology. By growing undifferentiated plant cells in controlled bioreactor environments, the company aims to produce full-spectrum phytonutrients and botanical compounds that are difficult to obtain through traditional farming methods. This approach is designed to deliver consistent, high-purity extracts with reduced environmental impact and supply-chain variability.

The company’s product portfolio focuses on applications across the cosmeceutical, nutraceutical and health-and-wellness markets.

Featured Articles

Receive News & Ratings for BioHarvest Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioHarvest Sciences and related companies with MarketBeat.com's FREE daily email newsletter.